Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by AAVantgarde Bio

AAVantgarde Founder and Chief Scientific Officer, Professor Alberto Auricchio, is elected as President of the European Society of Gene and Cell Therapy
From AAVantgarde Bio
Via GlobeNewswire
AAVantgarde appoints Ms. Lauren Kaskiel as Chief Business Officer
From AAVantgarde Bio
Via GlobeNewswire
AAVantgarde announces 3 oral presentations at ESGCT 2024 annual meeting
From AAVantgarde Bio
Via GlobeNewswire
AAVantgarde announces first patient dosed in First-In-Human Phase 1/2 LUCE-1 study, evaluating AAVB-081 (Dual-AAV) in retinitis pigmentosa related to Usher Syndrome type 1B
From AAVantgarde Bio
Via GlobeNewswire
AAVantgarde appoints Dr. Jayashree Sahni as Chief Medical Officer
From AAVantgarde Bio
Via GlobeNewswire
AAVantgarde announces its innovative clinical study design for its lead program in Usher 1B
From AAVantgarde Bio
Via GlobeNewswire
AAVantgarde announces updated NHP data from its Stargardt disease program in a poster presentation at the ARVO 2024 annual meeting
From AAVantgarde Bio
Via GlobeNewswire
AAVantgarde presents positive preclinical data in large animal models from its Stargardt disease program in an oral presentation at the ASGCT 2024 annual meeting
From AAVantgarde Bio
Via GlobeNewswire
AAVantgarde Closes €61 Million Series A Financing to Advance Two Therapeutic Programs into the Clinic
From AAVantgarde Bio
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.